Consun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase

Bulletin Express01-19

Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.

Between 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.

Additionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.

The announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170238152?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-19 20:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170238152","market":"hk","top_or_hot":-1,"title":"Consun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.</p>\n<p>Between 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.</p>\n<p>Additionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.</p>\n<p>The announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-19 20:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.</p>\n<p>Between 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.</p>\n<p>Additionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.</p>\n<p>The announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1170238152","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170238152","pubTimestamp":1768826554,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业(01681)公布股份发行及购回更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.\nBetween 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.\nAdditionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.\nThe announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170238152","isCrawlerRequest":true}